/FEED
FEED Stock - ENvue Medical, Inc.
Healthcare|Medical - SpecialtiesNASDAQ
$3.00-10.18%
$0.34 (-10.18%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.10
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.38
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+55.0%upside
Target: $4.65
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FEED
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.97 – $3.03
TARGET (TP)$4.65
STOP LOSS$2.76
RISK/REWARD1:6.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.06
52W High$5.00
52W Low$2.93
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.56M | $2.28M | $752,000 | $1.70M | $623,000 |
| Gross Profit | $1.51M | $1.54M | $167,000 | $770,000 | $214,000 |
| Gross Margin | 59.0% | 67.3% | 22.2% | 45.4% | 34.3% |
| Operating Income | $-3,582,000 | $-3,436,000 | $-5,012,000 | $-5,683,000 | $-4,719,000 |
| Net Income | $-3,705,000 | $-3,711,000 | $-5,448,000 | $-14,282,000 | $-4,325,000 |
| Net Margin | -144.8% | -162.5% | -724.5% | -842.6% | -694.2% |
| EPS | $-137.30 | $-233.25 | $-422.14 | $-1248.68 | $-923.96 |
Company Overview
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
FEEDLoading earnings data...
Frequently Asked Questions about FEED
What is FEED's current stock price?
ENvue Medical, Inc. (FEED) is currently trading at $3.00 per share. The stock has moved -10.18% today.
What is the analyst price target for FEED?
The average analyst price target for FEED is $4.65, based on 1 analyst.
What sector is ENvue Medical, Inc. in?
ENvue Medical, Inc. operates in the Healthcare sector, specifically within the Medical - Specialties industry. The company is traded on the NASDAQ exchange.
What is FEED's market cap?
ENvue Medical, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does FEED pay dividends?
No, ENvue Medical, Inc. does not currently pay a dividend to shareholders.